Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SHRM3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SHRM3 (Shroom Family Member 3) is an actin-binding protein involved in cellular morphogenesis, tissue development, and cytoskeletal dynamics. It plays critical roles in apical constriction, neural tube formation, and synaptic plasticity, with implications for neurodegenerative diseases.
No AI portrait yet
| Gene Symbol | SHRM3 |
| Full Name | Shroom Family Member 3 |
| Chromosome | 19q13.42 |
| Function | is an actin-binding protein that plays critical roles in cellular morphogenesis and tissue development [simic2018](https://pubmed. |
| Primary Expression | both developing and adult tissues, with particularly high expression in the nervous system and kidney [hatano2020](https://pubmed |
| Subcellular Localization | 2. **Central region**: Contains binding sites for actin and myosin |
| Molecular Weight | 210 kDa |
| Amino Acids | 1934 aa |
| Ensembl ID | ENSG00000104892 |
| GeneCards | SHRM3 |
| Human Protein Atlas | SHRM3 |
| Neural plate bending | Initiates folding of the neural plate |
| Neural fold elevation | Promotes elevation of neural folds |
| Fusion of folds | Facilitates closure at the midline |
| Spina bifida prevention | Proper SHRM3 function prevents neural tube defects |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
SHRM3["SHRM3"]
neurodegeneration["neurodegeneration"]
SHRM3 -->|"implicated in"| neurodegeneration
Neurodegenerative_Diseases{"Neurodegenerative Diseases"}
SHRM3 -->|"implicated in"| Neurodegenerative_Diseases
Synaptic_Plasticity(["Synaptic Plasticity"])
SHRM3 -->|"regulates"| Synaptic_Plasticity
style SHRM3 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#fff
style Neurodegenerative_Diseases fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Synaptic_Plasticity fill:#2a2a1a,stroke:#ffd54f,stroke-width:1px,color:#ffd54f| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SHRM3 in their description or question text
No additional research found